Shlomit Kfir‐Erenfeld

892 total citations
21 papers, 577 citations indexed

About

Shlomit Kfir‐Erenfeld is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shlomit Kfir‐Erenfeld has authored 21 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Shlomit Kfir‐Erenfeld's work include CAR-T cell therapy research (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Immune Cell Function and Interaction (3 papers). Shlomit Kfir‐Erenfeld is often cited by papers focused on CAR-T cell therapy research (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Immune Cell Function and Interaction (3 papers). Shlomit Kfir‐Erenfeld collaborates with scholars based in Israel, Germany and United States. Shlomit Kfir‐Erenfeld's co-authors include Eitan Yefenof, Ronit Vogt Sionov, Rachel Spokoini, Ofer Mandelboim, S. Doron, Rifaat Safadi, E. Philip Horwitz, Chamutal Gur, Polina Stepensky and Orly Elpeleg and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Gut.

In The Last Decade

Shlomit Kfir‐Erenfeld

20 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shlomit Kfir‐Erenfeld Israel 12 235 186 127 91 77 21 577
Xiuyuan Sun China 13 187 0.8× 256 1.4× 88 0.7× 46 0.5× 51 0.7× 36 517
Esther Bandala‐Sanchez Australia 16 334 1.4× 332 1.8× 104 0.8× 82 0.9× 94 1.2× 27 762
Marianna Greco Italy 13 125 0.5× 90 0.5× 79 0.6× 47 0.5× 20 0.3× 30 420
Jingtao Qiu China 12 197 0.8× 299 1.6× 88 0.7× 44 0.5× 48 0.6× 17 587
Sophie Sarret Switzerland 3 305 1.3× 279 1.5× 75 0.6× 84 0.9× 25 0.3× 3 562
Ruxandra Tudoran Germany 6 146 0.6× 345 1.9× 106 0.8× 118 1.3× 22 0.3× 8 691
Fabio Jiménez United States 14 191 0.8× 259 1.4× 215 1.7× 64 0.7× 24 0.3× 22 769
Sascha Hasan United States 6 254 1.1× 189 1.0× 85 0.7× 56 0.6× 50 0.6× 9 663
Bhavana Priyadharshini United States 10 174 0.7× 693 3.7× 182 1.4× 81 0.9× 83 1.1× 18 899
Nadeem Hafeez Butt Pakistan 14 340 1.4× 63 0.3× 47 0.4× 207 2.3× 78 1.0× 33 712

Countries citing papers authored by Shlomit Kfir‐Erenfeld

Since Specialization
Citations

This map shows the geographic impact of Shlomit Kfir‐Erenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shlomit Kfir‐Erenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shlomit Kfir‐Erenfeld more than expected).

Fields of papers citing papers by Shlomit Kfir‐Erenfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shlomit Kfir‐Erenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shlomit Kfir‐Erenfeld. The network helps show where Shlomit Kfir‐Erenfeld may publish in the future.

Co-authorship network of co-authors of Shlomit Kfir‐Erenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Shlomit Kfir‐Erenfeld. A scholar is included among the top collaborators of Shlomit Kfir‐Erenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shlomit Kfir‐Erenfeld. Shlomit Kfir‐Erenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Keller, Baerbel, Shlomit Kfir‐Erenfeld, Frederike A. Hartl, et al.. (2023). Combined Immunodeficiency Caused by a Novel Nonsense Mutation in LCK. Journal of Clinical Immunology. 44(1). 4–4. 4 indexed citations
3.
Assayag, Miri, Batia Avni, Shlomit Kfir‐Erenfeld, et al.. (2023). Early lymphocyte collection for anti‐CD19 CART production improves T‐cell fitness in patients with relapsed/refractory diffuse large B‐cell lymphoma. British Journal of Haematology. 202(1). 74–85. 15 indexed citations
4.
Vainstein, Vladimir, Batia Avni, Sigal Grisariu, et al.. (2023). Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?. Cancers. 15(13). 3471–3471. 8 indexed citations
5.
Kfir‐Erenfeld, Shlomit, Batia Avni, Sigal Grisariu, et al.. (2023). Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4852–4852. 1 indexed citations
6.
Kfir‐Erenfeld, Shlomit, Sigal Grisariu, Batia Avni, et al.. (2023). Feasibility of a Novel Academic Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Blood. 142(Supplement 1). 538–538. 8 indexed citations
7.
Kfir‐Erenfeld, Shlomit, Sigal Grisariu, Batia Avni, et al.. (2022). Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Clinical Cancer Research. 28(23). 5156–5166. 21 indexed citations
8.
Katz, Ben, Simon Edvardson, Channa Maayan, et al.. (2022). Nociception and pain in humans lacking a functional TRPV1 channel. Journal of Clinical Investigation. 133(3). 41 indexed citations
9.
Kfir‐Erenfeld, Shlomit, Batia Avni, Miri Assayag, et al.. (2022). Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial. Haematologica. 108(7). 1827–1839. 17 indexed citations
10.
Kfir‐Erenfeld, Shlomit, Tilda Barliya, Miri Assayag, et al.. (2022). Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma. Haematologica. 107(10). 2395–2407. 12 indexed citations
11.
Shadur, Bella, Shlomit Kfir‐Erenfeld, Adeeb NaserEddin, et al.. (2020). A human case of GIMAP6 deficiency: a novel primary immune deficiency. European Journal of Human Genetics. 29(4). 657–662. 7 indexed citations
12.
Kfir‐Erenfeld, Shlomit, et al.. (2016). miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis. Oncotarget. 8(1). 472–489. 29 indexed citations
13.
Ben‐Ami, Tal, Shoshana Revel‐Vilk, Rebecca Brooks, et al.. (2016). Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency. The Journal of Pediatrics. 177. 316–320. 64 indexed citations
14.
Kfir‐Erenfeld, Shlomit & Eitan Yefenof. (2013). Non-genomic events determining the sensitivity of hemopoietic malignancies to glucocorticoid-induced apoptosis. Cancer Immunology Immunotherapy. 63(1). 37–43. 18 indexed citations
15.
Ish‐Shalom, Eliran, et al.. (2012). Nitric oxide and glucocorticoids synergize in inducing apoptosis of CD4+8+ thymocytes: implications for ‘Death by Neglect’ and T-cell function. International Immunology. 24(12). 783–791. 5 indexed citations
16.
Gur, Chamutal, S. Doron, Shlomit Kfir‐Erenfeld, et al.. (2011). NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut. 61(6). 885–893. 137 indexed citations
17.
Spokoini, Rachel, Shlomit Kfir‐Erenfeld, Eitan Yefenof, & Ronit Vogt Sionov. (2010). Glycogen Synthase Kinase-3 Plays a Central Role in Mediating Glucocorticoid-Induced Apoptosis. Molecular Endocrinology. 24(6). 1136–1150. 63 indexed citations
18.
Kfir‐Erenfeld, Shlomit, et al.. (2010). Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations. Leukemia & lymphoma. 51(11). 1968–2005. 46 indexed citations
19.
Kfir‐Erenfeld, Shlomit, et al.. (2009). Nitric oxide cooperates with glucocorticoids in thymic epithelial cell-mediated apoptosis of double positive thymocytes. International Immunology. 21(10). 1113–1123. 9 indexed citations
20.
Sionov, Ronit Vogt, et al.. (2008). Chapter 6 Mechanisms Regulating the Susceptibility of Hematopoietic Malignancies to Glucocorticoid‐Induced Apoptosis. Advances in cancer research. 127–248. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiuyuan Sun Breakdown of academic impact, for papers by Esther Bandala‐Sanchez Breakdown of academic impact, for papers by Marianna Greco Breakdown of academic impact, for papers by Jingtao Qiu Breakdown of academic impact, for papers by Sophie Sarret Breakdown of academic impact, for papers by Ruxandra Tudoran Breakdown of academic impact, for papers by Fabio Jiménez Breakdown of academic impact, for papers by Sascha Hasan Breakdown of academic impact, for papers by Bhavana Priyadharshini Breakdown of academic impact, for papers by Nadeem Hafeez Butt
Rankless by CCL
2026